InsidersTradesSigma
Track the Citius Pharmaceuticals, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €18.7m. The latest transaction was reported on 30 August 2024 (Levée d'options). Among the most active insiders: Holuka Eugene Myron. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Citius Pharmaceuticals, Inc.是一家生物制药公司，专注于开发治疗严重疾病的创新疗法。该公司在纳斯达克上市，股票代码为CTXR。